Chemical Formula: C35H60O7

Chemical Formula C35H60O7

Found 57 metabolite its formula value is C35H60O7

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

(2S)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C35H60O7 (592.4338809999999)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C35H60O7 (592.4338809999999)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C35H60O7 (592.4338809999999)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Aromin

Aromin

C35H60O7 (592.4338809999999)


   

Montanacin E

Montanacin E

C35H60O7 (592.4338809999999)


   

Ikshusterol 3-O-glucoside

(2R,3R,4S,5S,6R)-2-[[(3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)


   

(24R)-24-ethyl-6beta-[(beta-D-glucopyranosyl)oxy]-5beta-cholest-9-ene-12alpha-ol|opuntisteroside

(24R)-24-ethyl-6beta-[(beta-D-glucopyranosyl)oxy]-5beta-cholest-9-ene-12alpha-ol|opuntisteroside

C35H60O7 (592.4338809999999)


   

C35H60O7

C35H60O7 (592.4338809999999)


   

Inundoside C

Inundoside C

C35H60O7 (592.4338809999999)


   

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/12:0/0:0)

C35H60O7 (592.4338809999999)


   

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4338809999999)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/12:0)

C35H60O7 (592.4338809999999)


   

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/12:0/0:0)

C35H60O7 (592.4338809999999)


   

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4338809999999)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/12:0)

C35H60O7 (592.4338809999999)


   

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/12:0/0:0)

C35H60O7 (592.4338809999999)


   

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(12:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C35H60O7 (592.4338809999999)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/12:0)

C35H60O7 (592.4338809999999)


   

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(i-12:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-12:0/0:0)

C35H60O7 (592.4338809999999)


   

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(i-12:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C35H60O7 (592.4338809999999)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-12:0)

C35H60O7 (592.4338809999999)


   

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(i-12:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-12:0/0:0)

C35H60O7 (592.4338809999999)


   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(i-12:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C35H60O7 (592.4338809999999)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-12:0)

C35H60O7 (592.4338809999999)


   

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(i-12:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-12:0/0:0)

C35H60O7 (592.4338809999999)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-12:0)

C35H60O7 (592.4338809999999)


   

ST 29:0;O;GlcA

ST 29:0;O;GlcA

C35H60O7 (592.4338809999999)


   

ST 29:1;O2;Hex

ST 29:1;O2;Hex

C35H60O7 (592.4338809999999)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5s)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)


   

(5s)-3-{[(2s,6r)-6-[(7s)-7-hydroxy-7-[(2s,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

(5s)-3-{[(2s,6r)-6-[(7s)-7-hydroxy-7-[(2s,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-2-oxoheptyl]oxan-2-yl]methyl}-5-methyl-5h-furan-2-one

C35H60O7 (592.4338809999999)


   

2-{[1-(7-hydroxy-5-isopropylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(7-hydroxy-5-isopropylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O7 (592.4338809999999)